2024-02-01Zeitschriftenartikel
Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023
| dc.contributor.author | Cai, Wei | |
| dc.contributor.author | Köndgen, Sophie | |
| dc.contributor.author | Tolksdorf, Kristin | |
| dc.contributor.author | Dürrwald, Ralf | |
| dc.contributor.author | Schuler, Ekkehard | |
| dc.contributor.author | Biere, Barbara | |
| dc.contributor.author | Schweiger, Brunhilde | |
| dc.contributor.author | Goerlitz, Luise | |
| dc.contributor.author | Haas, Walter | |
| dc.contributor.author | Wolff, Thorsten | |
| dc.contributor.author | Buda, Silke | |
| dc.contributor.author | Reiche, Janine | |
| dc.date.accessioned | 2026-03-25T13:00:28Z | |
| dc.date.available | 2026-03-25T13:00:28Z | |
| dc.date.issued | 2024-02-01 | none |
| dc.identifier.other | 10.2807/1560-7917.ES.2024.29.13.2300465 | |
| dc.identifier.uri | http://edoc.rki.de/176904/13589 | |
| dc.description.abstract | Background: Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. Aim: To describe, for children aged < 5 years, the 2021 and 2022/23 RSV seasons in Germany. Methods: Through data and 16,754 specimens from outpatient sentinel surveillance, we investigated RSV seasonality, circulating lineages, and affected children’s age distributions in 2021 and 2022/23. Available information about disease severity from hospital surveillance was analysed for patients with RSV-specific diagnosis codes (n = 13,104). Differences between RSV seasons were assessed by chi-squared test and age distributions trends by Mann–Kendall test. Results: RSV seasonality was irregular in 2021 (weeks 35–50) and 2022/23 (weeks 41–3) compared to pre-COVID-19 2011/12–2019/20 seasons (median weeks 51–12). RSV positivity rates (RSV-PR) were higher in 2021 (40% (522/1,291); p < 0.001) and 2022/23 (30% (299/990); p = 0.005) than in prior seasons (26% (1,430/5,511)). Known globally circulating RSV-A (lineages GA2.3.5 and GA2.3.6b) and RSV-B (lineage GB5.0.5a) strains, respectively, dominated in 2021 and 2022/23. In 2021, RSV-PRs were similar in 1 – < 2, 2 – < 3, 3 – < 4, and 4 – < 5-year-olds. RSV hospitalisation incidence in 2021 (1,114/100,000, p < 0.001) and in 2022/23 (1,034/100,000, p < 0.001) was approximately double that of previous seasons’ average (2014/15–2019/20: 584/100,000). In 2022/23, proportions of RSV patients admitted to intensive care units rose (8.5% (206/2,413)) relative to pre-COVID-19 seasons (6.8% (551/8,114); p = 0.004), as did those needing ventilator support (6.1% (146/2,413) vs 3.8% (310/8,114); p < 0.001). Conclusions: High RSV-infection risk in 2–4-year-olds in 2021 and increased disease severity in 2022/23 possibly result from lower baseline population immunity, after NPIs diminished exposure to RSV. | eng |
| dc.language.iso | eng | none |
| dc.publisher | Robert Koch-Institut | |
| dc.rights | (CC BY 3.0 DE) Namensnennung 3.0 Deutschland | ger |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/de/ | |
| dc.subject | acute respiratory infection | eng |
| dc.subject | children | eng |
| dc.subject | disease severity | eng |
| dc.subject | genotype | eng |
| dc.subject | lineage | eng |
| dc.subject | phylogeny | eng |
| dc.subject | respiratory syncytial virus | eng |
| dc.subject | surveillance | eng |
| dc.subject.ddc | 610 Medizin und Gesundheit | none |
| dc.title | Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023 | none |
| dc.type | article | |
| dc.identifier.urn | urn:nbn:de:0257-176904/13589-7 | |
| dc.type.version | publishedVersion | none |
| local.edoc.container-title | Eurosurveillance - Europe's journal on infectious disease surveillance, epidemiology, prevention and control | none |
| local.edoc.type-name | Zeitschriftenartikel | |
| local.edoc.container-type | periodical | |
| local.edoc.container-type-name | Zeitschrift | |
| local.edoc.container-publisher-name | European Centre for Disease Prevention and Control | none |
| local.edoc.container-reportyear | 2024 | none |
| local.edoc.container-firstpage | 1 | none |
| local.edoc.container-lastpage | 13 | none |
| dc.description.version | Peer Reviewed | none |
